Vaxcyte, Inc. PCVX Deferred Tax Assets and Other Non-Current Assets
Deferred Tax Assets and Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by Vaxcyte, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The official record: Vaxcyte, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vaxcyte, Inc.'s deferred tax assets and other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vaxcyte, Inc.'s deferred tax assets and other non-current assets?
- Vaxcyte, Inc. (PCVX) reported deferred tax assets and other non-current assets of $155.54M in Q1 2026.
- How has Vaxcyte, Inc.'s deferred tax assets and other non-current assets changed year-over-year?
- Vaxcyte, Inc.'s deferred tax assets and other non-current assets increased by 103.9% year-over-year, from $76.28M to $155.54M.
- What is the long-term trend for Vaxcyte, Inc.'s deferred tax assets and other non-current assets?
- Over 5 years (2020 to 2025), Vaxcyte, Inc.'s deferred tax assets and other non-current assets has grown at a 193.0% compound annual growth rate (CAGR), from $550K to $118.85M.